m+Medelevator.RU
← Поиск публикаций
Frontiers in bioengineering and biotechnology · 2026

Artificial mediators, protein carriers, and catalyst architecture in C1 bioconversion.

СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kang Sung Heuck, Khan Mohd Faheem, Kim Suk Min

Аннотация

Biological conversion of one-carbon (C1) feedstocks frequently requires coupling oxidative and reductive reactions through an appropriate electron-transfer pathway. The combination of carbon monoxide dehydrogenase (CODH), which oxidizes CO to CO2, and formate dehydrogenase (FDH), which reduces CO2 to formate, serves as a representative model for examining this requirement. CODH-FDH coupling has been investigated in cell-free systems, whereas intracellular and distributed configurations provide emerging or prospective routes for extending this reaction across different biological environments. However, the relationship between electron carrier selection and system implementation is not one-to-one. Small artificial mediators such as viologens can connect physically separated enzymes or cells when they can access the relevant redox components, whereas protein carriers such as ferredoxins generally favor arrangements in which compatible partners share an accessible intracellular environment. When reactions are divided between cell populations, the connection may instead depend on a diffusible redox metabolite or an engineered conductive interface. Carrier mobility, accessibility across physical boundaries, partner recognition, and chemical stability constrain the range of system arrangements available for C1 bioconversion. Using CODH and FDH as a representative model, this Mini Review examines how electron-carrier properties and spatial organization shape C1 bioconversion architectures under process-relevant conditions.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты